Masanori Atsukawa

7PUBLICATIONS
37CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsPredictive and prognostic markersMolecular targetsHaematological tumoursCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 04, 2026
Superior Efficacy of Tenofovir Alafenamide Compared With Entecavir in Reducing Hepatitis B Surface Antigen: A Multicentre Propensity Score-Matched Study Using Linear Mixed-Effects Models.

|Jul 04, 2024
Clinical significance of circulating biomarkers of immune-checkpoint molecules with atezolizumab plus bevacizumab therapy in unresectable hepatocellular carcinoma.

Makoto Chuma, Haruki Uojima, Hidenori Toyoda

|Apr 10, 2021
Therapeutic efficacy of lenvatinib as third-line treatment after regorafenib for unresectable hepatocellular carcinoma progression.

Atsushi Hiraoka, Takashi Kumada, Takeshi Hatanaka

|Dec 03, 2020
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysis.

Makoto Chuma, Haruki Uojima, Atsushi Hiraoka

|Oct 16, 2020
Safety and Efficacy of Lenvatinib Treatment in Child-Pugh A and B Patients with Unresectable Hepatocellular Carcinoma in Clinical Practice: A Multicenter Analysis.

Katsuaki Ogushi, Makoto Chuma, Haruki Uojima

|Jan 18, 2020
Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan.

Hidenori Toyoda, Masanori Atsukawa, Tsunamasa Watanabe

Pageof 2

Frequent Collaborators

4 joint publications

Hidenori Toyoda

4 joint publications

Toshifumi Tada

3 joint publications

Takashi Kumada

2 joint publications

Kazuhiro Nouso